[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

RS58064B1 - Tapentadol za sprečavanje hronifikacije bola - Google Patents

Tapentadol za sprečavanje hronifikacije bola

Info

Publication number
RS58064B1
RS58064B1 RS20181507A RSP20181507A RS58064B1 RS 58064 B1 RS58064 B1 RS 58064B1 RS 20181507 A RS20181507 A RS 20181507A RS P20181507 A RSP20181507 A RS P20181507A RS 58064 B1 RS58064 B1 RS 58064B1
Authority
RS
Serbia
Prior art keywords
chronification
tapentadol
pain
preventing
preventing chronification
Prior art date
Application number
RS20181507A
Other languages
English (en)
Inventor
Klaus Schiene
Ilona Steigerwald
Michel Hamon
Johannes Schneider
Silvia Reinartz
Ulrich Jahnel
Thomas Tzschentke
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46025592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS58064(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of RS58064B1 publication Critical patent/RS58064B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RS20181507A 2011-04-05 2012-04-03 Tapentadol za sprečavanje hronifikacije bola RS58064B1 (sr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11002811 2011-04-05
EP11003508 2011-04-29
EP12718064.4A EP2694049B1 (en) 2011-04-05 2012-04-03 Tapentadol for preventing chronification of pain
PCT/EP2012/001472 WO2012136349A1 (en) 2011-04-05 2012-04-03 Tapentadol for preventing chronification of pain

Publications (1)

Publication Number Publication Date
RS58064B1 true RS58064B1 (sr) 2019-02-28

Family

ID=46025592

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20181507A RS58064B1 (sr) 2011-04-05 2012-04-03 Tapentadol za sprečavanje hronifikacije bola

Country Status (13)

Country Link
US (3) US20120309841A1 (sr)
EP (2) EP2694049B1 (sr)
JP (3) JP2014510759A (sr)
CY (1) CY1121012T1 (sr)
DK (1) DK2694049T3 (sr)
ES (1) ES2703282T3 (sr)
HR (1) HRP20181998T1 (sr)
LT (1) LT2694049T (sr)
PL (1) PL2694049T3 (sr)
PT (1) PT2694049T (sr)
RS (1) RS58064B1 (sr)
SI (1) SI2694049T1 (sr)
WO (1) WO2012136349A1 (sr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2694049B1 (en) 2011-04-05 2018-10-31 Grünenthal GmbH Tapentadol for preventing chronification of pain
SI2701693T1 (sl) 2011-04-29 2017-11-30 Gruenenthal Gmbh Tapentadol za preprečevanje in zdravljenje depresije in anksioznosti
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
AU2021201351B1 (en) * 2020-11-10 2022-04-21 Grünenthal GmbH Dosage form providing prolonged release of a salt of Tapentadol with L-(+)-tartaric acid

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
EP2179741B1 (en) 2005-08-26 2014-10-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for treatment of headaches by administraton of oxytocin
US20090306050A1 (en) 2006-02-03 2009-12-10 Timothy Dinan Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain
CA2649459C (en) * 2006-04-28 2014-07-22 Gruenenthal Gmbh Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid
DE102007012165A1 (de) 2007-03-12 2008-09-18 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
CN102908339A (zh) * 2007-11-23 2013-02-06 格吕伦塔尔有限公司 他喷他多组合物
WO2009082039A1 (en) 2007-12-26 2009-07-02 Eisai R & D Management Co., Ltd. Ampa receptor antagonists for epilepsy, mental disorders or deficits in sensory organ
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
WO2009094563A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use
US20100227921A1 (en) 2009-03-03 2010-09-09 Shire Llc Amino acid and peptide carbamate prodrugs of tapentadol and uses thereof
JP5993303B2 (ja) 2009-04-30 2016-09-14 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング リウマチ性痛を治療するための１−フェニル−３−ジメチルアミノプロパン化合物の使用
FR2970261B1 (fr) 2011-01-10 2013-05-03 IFP Energies Nouvelles Procede d'hydrotraitement de charges lourdes d'hydrocarbures avec des reacteurs permutables incluant au moins une etape de permutation progressive
EP2694049B1 (en) * 2011-04-05 2018-10-31 Grünenthal GmbH Tapentadol for preventing chronification of pain

Also Published As

Publication number Publication date
US20160354324A1 (en) 2016-12-08
ES2703282T3 (es) 2019-03-07
US10398657B2 (en) 2019-09-03
US20120309841A1 (en) 2012-12-06
JP2018048122A (ja) 2018-03-29
EP3449917A3 (en) 2019-06-05
JP6840057B2 (ja) 2021-03-10
LT2694049T (lt) 2018-12-27
JP2019142932A (ja) 2019-08-29
WO2012136349A1 (en) 2012-10-11
PT2694049T (pt) 2019-02-06
HRP20181998T1 (hr) 2019-01-25
US10813891B2 (en) 2020-10-27
SI2694049T1 (sl) 2019-01-31
JP2014510759A (ja) 2014-05-01
EP2694049B1 (en) 2018-10-31
DK2694049T3 (da) 2019-01-02
EP2694049A1 (en) 2014-02-12
PL2694049T3 (pl) 2019-07-31
CY1121012T1 (el) 2019-12-11
US20200009083A1 (en) 2020-01-09
EP3449917A2 (en) 2019-03-06

Similar Documents

Publication Publication Date Title
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
EP2673286A4 (en) THERAPEUTIC COMPOUNDS
EP2739221A4 (en) SURGICAL ANCHOR
EP2717855A4 (en) PROCESSING METHODS
EP2740420A4 (en) THERAPEUTIC TOOL
EP2671565A4 (en) EXTERNAL PREPARATION FOR THE SKIN
IL230433A0 (en) Pain management methods
ZA201502595B (en) Therapeutic methods
HRP20181998T1 (hr) Tapentadol za sprječavanje kronifikacije boli
EP2750508A4 (en) COMPOUNDS AND THERAPEUTIC METHODS
IL232239A0 (en) Medical use
EP2684869A4 (en) PREPARATION OF 3-MERCAPOTOPROPIONATES
GB201107467D0 (en) Novel treatment of pain
ZA201308117B (en) Avian-based treatment
GB201104632D0 (en) Use of medicament
GB201110895D0 (en) Therapeutic use
GB201105933D0 (en) Medical applicator
GB201110602D0 (en) Methods of treatment
GB201109737D0 (en) Methods of treatment
GB201111247D0 (en) Treatment
GB201109119D0 (en) Treatment
GB201102271D0 (en) Treatment
GB201102277D0 (en) Treatment
GB201102270D0 (en) Treatment
GB201102267D0 (en) Treatment